scholarly journals Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function

2007 ◽  
Vol 6 (3) ◽  
pp. 314-318 ◽  
Author(s):  
K. Doddakula ◽  
N. Al-Sarraf ◽  
K. Gately ◽  
A. Hughes ◽  
M. Tolan ◽  
...  
2015 ◽  
Vol 3 ◽  
pp. 195-198
Author(s):  
Pawel Nawrocki ◽  
Ireneusz Szwedo ◽  
Joanna Tyc ◽  
Anna Hawrysz ◽  
Kamila Janiak ◽  
...  

2004 ◽  
Vol 21 (Supplement 32) ◽  
pp. 171
Author(s):  
M. Luchian ◽  
D. Filipescu ◽  
I. Raileanu ◽  
M. Cristea ◽  
O. Ghenu ◽  
...  

Author(s):  
Quentin Milner

This chapter describes the anaesthetic management of the patient with renal disease. The topics include estimation of renal function, chronic kidney disease, renal replacement therapy (including haemodialysis), acute renal failure, and the patient with a transplanted kidney. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described. The effects of impaired renal function on the elimination of anaesthetic drugs are discussed.


Renal Failure ◽  
2005 ◽  
Vol 27 (4) ◽  
pp. 385-392
Author(s):  
Ortrud Vargas Hein ◽  
M. Staegemann ◽  
D. Wagner ◽  
C. von Heymann ◽  
M. Martin ◽  
...  

2002 ◽  
Vol 15 (5) ◽  
pp. 392-404
Author(s):  
Mary K. Stamatakis

Acute renal failure (ARF) is a potentially life-threatening medical condition that often complicates the hospitalization of critically ill patients. A variety of therapeutic strategies has been studied for both preventing ischemic and nephrotoxic injury to the kidney and improving renal function in established ARF. This article summarizes the role of pharmacologic therapy in the treatment of ARF. Strategies to reduce extracellular fluid volume and preserve renal function with loop diuretics, low-dose dopamine, and renal replacement therapy will be discussed. The value of preventative therapy has increased, and identifying patients at high risk for development of ARF is critical. Modification of drug regimens, administration of less nephrotoxic medications, and volume expansion prior to nephrotoxin administration can minimize toxicity to the kidney. The search for new agents that can improve survival, decrease the need for renal replacement therapy, and hasten the recovery of renal function in ARF is ongoing.


2014 ◽  
pp. 147-53
Author(s):  
Juweni Joe ◽  
Zuswahyuda Samsu ◽  
April Retno ◽  
Rita Zahara ◽  
Ronggo Prakoso ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document